The Scientist

» FDA and developmental biology

Most Recent

image: FDA OKs Zika Test for Blood Donations

FDA OKs Zika Test for Blood Donations

By | March 31, 2016

The US Food and Drug Administration approves conditional use of an investigational test for Zika virus.

0 Comments

image: FDA Head Confirmed

FDA Head Confirmed

By | February 24, 2016

The US Senate approves the Obama administration’s nominee, Robert Califf, as the next commissioner of the Food and Drug Administration.

0 Comments

image: FDA to Test for Glyphosate in Food

FDA to Test for Glyphosate in Food

By | February 22, 2016

The US Food and Drug Administration will begin testing certain foods for residues of the active ingredient in the herbicide Roundup.

1 Comment

image: Adjustable Brain Cells

Adjustable Brain Cells

By | February 18, 2016

Neighboring neurons can manipulate astrocytes. 

1 Comment

image: Disclosure of Problematic Scopes Delayed: Report

Disclosure of Problematic Scopes Delayed: Report

By | January 14, 2016

The US Senate has found hospitals, a device maker, and federal regulators dragged their feet on reporting contaminated endoscopes.

0 Comments

image: Picking Up the Pace

Picking Up the Pace

By | January 1, 2016

FDA designations promise to expedite the approval of drugs for conditions ranging from infectious disease to cancer.

0 Comments

image: Diagnostics Group Refutes FDA’s Concerns

Diagnostics Group Refutes FDA’s Concerns

By | December 17, 2015

The Association for Molecular Pathology finds fault in the agency’s report on safety issues associated with certain lab tests.

0 Comments

image: Drug Produced in GM Chicken Approved

Drug Produced in GM Chicken Approved

By | December 10, 2015

The US Food and Drug Administration greenlights a rare-disease drug that is produced in the eggs of genetically modified chickens.

1 Comment

image: The Cyclopes of Idaho, 1950s

The Cyclopes of Idaho, 1950s

By | December 1, 2015

A rash of deformed lambs eventually led to the creation of a cancer-fighting agent.

0 Comments

image: Fatal-Disease Drug in Limbo

Fatal-Disease Drug in Limbo

By | November 25, 2015

A panel of experts advised the US Food and Drug Administration that BioMarin Pharmaceutical has not demonstrated efficacy of its new drug for Duchenne muscular dystrophy.

0 Comments

Popular Now

  1. Exercise Boosts Telomere Transcription
  2. Classic Example of Symbiosis Revised
  3. The Genetic Components of Rare Diseases
  4. Orangutan Imitates Human Speech
RayBiotech